Automated Cellular-Level Dual Global Fusion of Whole-Slide Imaging for Lung Adenocarcinoma Prognosis.

cellular architecture embedded features global fusion lung adenocarcinoma survival prediction whole-slide image

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
01 Oct 2023
Historique:
received: 08 09 2023
revised: 24 09 2023
accepted: 27 09 2023
medline: 14 10 2023
pubmed: 14 10 2023
entrez: 14 10 2023
Statut: epublish

Résumé

Histopathologic whole-slide images (WSI) are generally considered the gold standard for cancer diagnosis and prognosis. Survival prediction based on WSI has recently attracted substantial attention. Nevertheless, it remains a central challenge owing to the inherent difficulties of predicting patient prognosis and effectively extracting informative survival-specific representations from WSI with highly compounded gigapixels. In this study, we present a fully automated cellular-level dual global fusion pipeline for survival prediction. Specifically, the proposed method first describes the composition of different cell populations on WSI. Then, it generates dimension-reduced WSI-embedded maps, allowing for efficient investigation of the tumor microenvironment. In addition, we introduce a novel dual global fusion network to incorporate global and inter-patch features of cell distribution, which enables the sufficient fusion of different types and locations of cells. We further validate the proposed pipeline using The Cancer Genome Atlas lung adenocarcinoma dataset. Our model achieves a C-index of 0.675 (±0.05) in the five-fold cross-validation setting and surpasses comparable methods. Further, we extensively analyze embedded map features and survival probabilities. These experimental results manifest the potential of our proposed pipeline for applications using WSI in lung adenocarcinoma and other malignancies.

Identifiants

pubmed: 37835518
pii: cancers15194824
doi: 10.3390/cancers15194824
pmc: PMC10571722
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Sci Rep. 2022 Dec 19;12(1):21948
pubmed: 36536017
Med Image Anal. 2021 Feb;68:101903
pubmed: 33352373
Lab Invest. 2018 Nov;98(11):1438-1448
pubmed: 29959421
Am J Pathol. 2020 Aug;190(8):1691-1700
pubmed: 32360568
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Med Image Anal. 2019 Dec;58:101563
pubmed: 31561183
Cancer. 1997 Feb 15;79(4):665-7
pubmed: 9024702
Aging (Albany NY). 2020 Feb 24;12(4):3312-3339
pubmed: 32091408
Am J Pathol. 2022 Mar;192(3):553-563
pubmed: 34896390
Stat Med. 2005 Dec 30;24(24):3927-44
pubmed: 16320281
Med Image Anal. 2020 Oct;65:101789
pubmed: 32739769
Mayo Clin Proc. 2019 Aug;94(8):1623-1640
pubmed: 31378236
Eur J Cancer. 2019 Jul;115:79-83
pubmed: 31129383
Mod Pathol. 2017 Dec;30(12):1655-1665
pubmed: 28776575
Mod Pathol. 2023 Sep 9;36(12):100326
pubmed: 37678674
Diagnostics (Basel). 2022 Mar 21;12(3):
pubmed: 35328321
Comput Intell Neurosci. 2018 Sep 12;2018:2061516
pubmed: 30298088
PLoS One. 2012;7(12):e51862
pubmed: 23251644
Cancers (Basel). 2019 Oct 28;11(11):
pubmed: 31661863
Cancer Invest. 2009 Mar;27(3):235-43
pubmed: 19291527
Nature. 2021 Jun;594(7861):106-110
pubmed: 33953404
J Thorac Oncol. 2017 Mar;12(3):501-509
pubmed: 27826035
Sci Rep. 2022 Aug 25;12(1):14527
pubmed: 36008541
BMC Bioinformatics. 2020 Sep 30;21(Suppl 14):368
pubmed: 32998690
Am J Pathol. 2023 Oct;193(10):1517-1527
pubmed: 37356573

Auteurs

Songhui Diao (S)

Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.
Shenzhen College of Advanced Technology, University of Chinese Academy of Sciences, Shenzhen 518055, China.
Department of Imaging Physics, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Pingjun Chen (P)

Department of Imaging Physics, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Eman Showkatian (E)

Department of Imaging Physics, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Rukhmini Bandyopadhyay (R)

Department of Imaging Physics, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Frank R Rojas (FR)

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Bo Zhu (B)

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Lingzhi Hong (L)

Department of Imaging Physics, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Muhammad Aminu (M)

Department of Imaging Physics, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Maliazurina B Saad (MB)

Department of Imaging Physics, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Morteza Salehjahromi (M)

Department of Imaging Physics, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Amgad Muneer (A)

Department of Imaging Physics, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Sheeba J Sujit (SJ)

Department of Imaging Physics, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Carmen Behrens (C)

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Don L Gibbons (DL)

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

John V Heymach (JV)

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Neda Kalhor (N)

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Ignacio I Wistuba (II)

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Luisa M Solis Soto (LM)

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Jianjun Zhang (J)

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Wenjian Qin (W)

Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.

Jia Wu (J)

Department of Imaging Physics, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Classifications MeSH